AOP2 AND ATHEROSCLEROSIS RESISTANCE AND MICE
AOP2 AND ATHEROSCLEROSIS RESISTANCE AND MICE
批准号:
6343492
负责人:
Shelley A Phelan
金额:
$3.92万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2000
资助国家:
美国
项目状态:
未结题
起止时间:
2000-12-12 至
关键词:
animal breeding atherosclerosis disease /disorder model gene expression genetic promoter element genetic susceptibility genetically modified animals in situ hybridization laboratory mouse model design /development molecular cloning nucleic acid sequence oxidative stress polymerase chain reaction tissue /cell culture
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION
Previous studies from our laboratory have demonstrated that susceptibility
to atherosclerosis differs significantly between inbred strains of mice,
suggesting a strong genetic component to the disease. Athl is a
quantitative trait locus that we found to be associated with decreased
plasma HDL-cholesterol levels and increased atherosclerotic lesion
formation in susceptible strains of mice when fed a high fat diet. We have
recently identified a Athl candidate gene, Aop2, which is a member of the
thiol-specific antioxidant family. We believe Aop2 mediates protection
from atherosclerosis based on its chromosomal co-localization with Athl,
mRNA induction by high fat diet, amino acid and expression differences
between resistant and susceptible strains, and the proposed role of LDL
oxidation in the pathogenesis of atherosclerosis. I propose three specific
aims toward the characterization of AOP2 in atherosclerosis resistance: 1)
obtain definitive proof that AOP2 confers resistance to atherosclerosis by
transgenic rescue; 2) characterize expression of AOP2 in the arterial
wall; and 3) determine the molecular basis for the regulatory differences
observed between atherosclerosis resistant and susceptible strains.
期刊论文(17)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Muscarinic cholinergic receptors in developing rat lung.
发育中的大鼠肺中的毒蕈碱胆碱能受体。
DOI:
10.1203/00006450-198411000-00016
发表时间:
1984
期刊:
Pediatric research
影响因子:
3.6
作者:
[Whitsett,JA, Hollinger,B]
通讯作者:
Hollinger,B
Biophysical activity of synthetic phospholipids combined with purified lung surfactant 6000 dalton apoprotein.
合成磷脂与纯化的肺表面活性剂 6000 道尔顿脱辅基蛋白结合的生物物理活性。
DOI:
10.1016/0009-3084(87)90002-8
发表时间:
1987
期刊:
Chemistry and physics of lipids
影响因子:
3.4
作者:
[Notter,RH, Shapiro,DL, Ohning,B, Whitsett,JA]
通讯作者:
Whitsett,JA
Intracellular and oligomeric forms of surfactant-associated apolipoproteins(s) A in the rat.
大鼠体内表面活性剂相关载脂蛋白 A 的细胞内和寡聚形式。
DOI:
10.1016/0167-4838(85)90210-9
发表时间:
1985
期刊:
Biochimica et biophysica acta
影响因子:
--
作者:
[Weaver,TE, Hull,WM, Ross,GF, Whitsett,JA]
通讯作者:
Whitsett,JA
DOI:
10.1016/s0021-9258(18)95731-5
发表时间:
1985-12
期刊:
The Journal of biological chemistry
影响因子:
--
作者:
[J. Whitsett;G. Ross;T. Weaver;W. Rice;C. Dion;W. Hull]
通讯作者:
J. Whitsett;G. Ross;T. Weaver;W. Rice;C. Dion;W. Hull
Structural relationships of the major glycoproteins from human alveolar proteinosis surfactant.
人肺泡蛋白沉积表面活性剂主要糖蛋白的结构关系。
DOI:
10.1016/0167-4838(87)90070-7
发表时间:
1987
期刊:
Biochimica et biophysica acta
影响因子:
--
作者:
[Ross,GF, Ohning,BL, Tannenbaum,D, Whitsett,JA]
通讯作者:
Whitsett,JA
共 13 条
Broadening Access to Science Education
-
批准号:8260060
-
项目类别:
-
资助金额:$7.48万
-
财政年份:2011
-
负责人:Shelley A Phelan
-
依托单位:
Broadening Access to Science Education
-
批准号:8667338
-
项目类别:
-
资助金额:$7.4万
-
财政年份:2011
-
负责人:Shelley A Phelan
-
依托单位:
Broadening Access to Science Education
-
批准号:8308417
-
项目类别:
-
资助金额:$7.42万
-
财政年份:2011
-
负责人:Shelley A Phelan
-
依托单位:
Broadening Access to Science Education
-
批准号:8487259
-
项目类别:
-
资助金额:$6.92万
-
财政年份:2011
-
负责人:Shelley A Phelan
-
依托单位:
AOP2 AND ATHEROSCLEROSIS RESISTANCE AND MICE
-
批准号:2767602
-
项目类别:
-
资助金额:$3.17万
-
财政年份:1999
-
负责人:Shelley A Phelan
-
依托单位:
AOP2 AND ATHEROSCLEROSIS RESISTANCE AND MICE
-
批准号:6139127
-
项目类别:
-
资助金额:$3.67万
-
财政年份:1999
-
负责人:Shelley A Phelan
-
依托单位:
海外基金